TCR signaling: Another Abl-bodied kinase joins the cascade

Current Biology

Volumn 14, Issue 14, 2004, Pages

  Wange, Ronald L ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3343021931     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.07.012     Document Type: Review

References (18)

1. Wange R.L. Proximal events in T cell antigen receptor signaling. Schmitz L., Bacher S. Mechanisms of Signal Transduction and Inducible Gene Expression. 2004;21-51 Research Signpost, Kerala
2. Wange R.L., Huang Y. T cell receptor signaling: Beyond complex complexes. J. Biol. Chem. 279:2004;28827-28830
3. Iwashima M., Irving B.A., van Oers N.S., Chan A.C., Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 263:1994;1136-1139
4. Zipfel P.A., Zhang W., Quiroz M., Pendergast A.M. Requirement for Abl kinases in T cell receptor signaling. Curr. Biol. 14:2004;. this issue
5. Pendergast A.M. The Abl family kinases: mechanisms of regulation and signaling. Adv. Cancer Res. 85:2002;51-100
6. Schwartzberg P.L., Stall A.M., Hardin J.D., Bowdish K.S., Humaran T., Boast S., Harbison M.L., Robertson E.J., Goff S.P. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell. 65:1991;1165-1175
7. Tybulewicz V.L., Crawford C.E., Jackson P.K., Bronson R.T., Mulligan R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1991;1153-1163
8. Mak T.W., Penninger J.M., Ohashi P.S. Knockout mice: a paradigm shift in modern immunology. Nat. Rev. Immunol. 1:2001;11-19
9. Druker B.J. Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML. Oncogene. 21:2002;8541-8546
10. Williams B.L., Irvin B.J., Sutor S.L., Chini C.C., Yacyshyn E., Bubeck Wardenburg J., Dalton M., Chan A.C., Abraham R.T. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J. 18:1999;1832-1844
11. Shan X., Wange R.L. Itk/Emt/Tsk activation in response to CD3 cross-linking in Jurkat T cells requires ZAP-70 and Lat and is independent of membrane recruitment. J. Biol. Chem. 274:1999;29323-29330
12. Shan X., Balakir R., Criado G., Wood J.S., Seminario M.C., Madrenas J., Wange R.L. Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation. Mol. Cell. Biol. 21:2001;7137-7149
13. Neumeister E.N., Zhu Y., Richard S., Terhorst C., Chan A.C., Shaw A.S. Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol. Cell. Biol. 15:1995;3171-3178
14. Di Bartolo V., Mege D., Germain V., Pelosi M., Dufour E., Michel F., Magistrelli G., Isacchi A., Acuto O. Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling. J. Biol. Chem. 274:1999;6285-6294
15. Pelosi M., Di B., Mounier V., Mege D., Pascussi J.M., Dufour E., Blondel A., Acuto O. Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J. Biol. Chem. 274:1999;14229-14237
16. Gelkop S., Babichev Y., Kalifa R., Tamir A., Isakov N. Involvement of crk adapter proteins in regulation of lymphoid cell functions. Immunol. Res. 28:2003;79-91
17. Mattiuzzi G.N., Cortes J.E., Talpaz M., Reuben J., Rios M.B., Shan J., Kontoyiannis D., Giles F.J., Raad I., Verstovsek S., et al. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin. Cancer Res. 9:2003;976-980
18. Bekkenk M.W., Vermeer M.H., Meijer C.J., Jansen P.M., Middeldorp J.M., Stevens S.J., Willemze R. EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate. Blood. 102:2003;4243